Telomir Pharmaceuticals Is A Biotech Pump And Dump Scheme Remaining In the Preclinical Stage – White Diamond Research
Telomir Pharmaceuticals (TELO) exposed: Biotech pump and dump scheme with missing preclinical data, questionable founder history, extreme overvaluation, and potential stock collapse under $1 in 2025